These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27313498)

  • 1. Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.
    Yan B; Zhao D; Yao Y; Bao Z; Lu G; Zhou J
    Int J Biol Sci; 2016; 12(7):850-60. PubMed ID: 27313498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.
    Yang YL; Ji C; Bi ZG; Lu CC; Wang R; Gu B; Cheng L
    PLoS One; 2013; 8(1):e54736. PubMed ID: 23372762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
    Lee HY; Suh YA; Kosmeder JW; Pezzuto JM; Hong WK; Kurie JM
    Clin Cancer Res; 2004 Feb; 10(3):1074-9. PubMed ID: 14871987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.
    Li W; Yu X; Xia Z; Yu X; Xie L; Ma X; Zhou H; Liu L; Wang J; Yang Y; Liu H
    J Cell Mol Med; 2018 Dec; 22(12):6213-6227. PubMed ID: 30255595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of deguelin on H460 human lung cancer cells in vitro and in vivo: Roles of apoptotic cell death and H460 tumor xenografts model.
    Hsu YC; Chiang JH; Yu CS; Hsia TC; Wu RS; Lien JC; Lai KC; Yu FS; Chung JG
    Environ Toxicol; 2017 Jan; 32(1):84-98. PubMed ID: 26592500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.
    Kang HW; Kim JM; Cha MY; Jung HC; Song IS; Kim JS
    Dig Dis Sci; 2012 Nov; 57(11):2873-82. PubMed ID: 22623043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.
    Baba Y; Fujii M; Maeda T; Suzuki A; Yuzawa S; Kato Y
    Biomed Res Int; 2015; 2015():657179. PubMed ID: 26075254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.
    Li W; Yu X; Ma X; Xie L; Xia Z; Liu L; Yu X; Wang J; Zhou H; Zhou X; Yang Y; Liu H
    Cell Signal; 2018 Oct; 50():131-141. PubMed ID: 30018008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deguelin induces PUMA-mediated apoptosis and promotes sensitivity of lung cancer cells (LCCs) to doxorubicin (Dox).
    Wang A; Wang W; Chen Y; Ma F; Wei X; Bi Y
    Mol Cell Biochem; 2018 May; 442(1-2):177-186. PubMed ID: 29030732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
    Li W; Gao F; Ma X; Wang R; Dong X; Wang W
    Oncotarget; 2017 May; 8(20):32586-32599. PubMed ID: 28427230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.
    Murillo G; Peng X; Torres KE; Mehta RG
    Cancer Prev Res (Phila); 2009 Nov; 2(11):942-50. PubMed ID: 19861542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
    Zhao H; Jiao Y; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells.
    Peng XH; Karna P; O'Regan RM; Liu X; Naithani R; Moriarty RM; Wood WC; Lee HY; Yang L
    Mol Pharmacol; 2007 Jan; 71(1):101-11. PubMed ID: 17035597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
    Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
    Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis.
    Woo JK; Choi DS; Tran HT; Gilbert BE; Hong WK; Lee HY
    Cancer Prev Res (Phila); 2009 Apr; 2(4):361-9. PubMed ID: 19336726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
    Hsu YL; Wu CY; Hung JY; Lin YS; Huang MS; Kuo PL
    Carcinogenesis; 2013 Jun; 34(6):1370-81. PubMed ID: 23389289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
    Kim WY; Chang DJ; Hennessy B; Kang HJ; Yoo J; Han SH; Kim YS; Park HJ; Seo SY; Mills G; Kim KW; Hong WK; Suh YG; Lee HY
    Cancer Prev Res (Phila); 2008 Dec; 1(7):577-87. PubMed ID: 19139008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.